Envoy Medical, Inc.
COCH· Nasdaq
COCHEnvoy Medical, Inc.
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001410578-23-001937
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $63.00K | — | — |
| Net Income | -$13.34M | -$1.24M | $371.14K |
| EPS Diluted | -$1.31 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
